Medical Patent News

RSS

AstraZeneca files for patent infringement

AstraZeneca has confirmed that it has filed a lawsuit in the U.S. District Court for the District of Delaware against the generic company Andrx for patent infringement.

23 Jul 2004

Cancer Research Technology grants exclusive license to Genentech to patent portfolio of an oncology target

Cancer Research Technology announced today that it has entered into a license agreement granting Genentech, Inc. exclusive worldwide rights to its patent portfolio covering an oncology target discovered in the Molecular Oncology Laboratory (Oxford) of Cancer Research UK.

21 Jul 2004

New SARS air filter

Matsushita (Panasonic) has announced its environment-related subsidiary, Matsushita Ecology Systems Co., Ltd., has developed a revolutionary SARS air filter.

15 Jul 2004

AIDS Healthcare Foundation targets GSK over voluntary licensing of its AIDS drug patents in South Africa

At the international AIDS conference in Bangkok, AIDS Healthcare Foundation hosted a peaceful protest against British multinational pharmaceutical giant GlaxoSmithKline over its voluntary licensing of its AIDS drug patents in South Africa.

13 Jul 2004

Patent for orally administrable pharmaceutical may aid treatment of overdose patients

Global nanotechnology company pSivida Limited, is pleased to announce that its UK operating subsidiary pSiMedica Limited has been granted a new Australian patent for BioSiliconTM.

30 Jun 2004

Nanogen issued patent for a new technique to detect genetic variants

The '148 patent is a continuation of patents issued to Nanogen that cover methods and apparatus that are particularly useful for detecting varying lengths of genetic variants.

25 Jun 2004

First-ever microfluidic BioMEMS device to study the mechanisms of cell migration and deformation

Cancer cells have the ability to invade blood vessels and find their way into the bloodstream. Once there, these infected cells can easily travel to other parts of the body and attack healthy organs.

25 Jun 2004

New patent for screening technology

MorphoSys AG announced today that the U.S. Patent & Trademark Office has granted a new patent on its proprietary CysDisplay™ screening technology.

24 Jun 2004

Xenobiotic gets patent approval for toxin detection

XDS consultant (and former XDS laboratory director) Michael Chu and President George Clark combined their research skills to develop a rapid and relatively inexpensive methodology to quantify TEQs (Toxic Equivalence -- measures of toxicity adopted by the World Health Organization) for individual toxic chemical groups.

17 Jun 2004

Patent issued for GHB, date rape drug test

A patent for a highly sensitive test to detect the presence of the "date rape" drug, GHB, has recently been granted to the University of California, Santa Barbara.

9 Jun 2004

New medical patent covering the generation of genetically enhanced therapeutic antigens

Morphotek, Inc. announced today the issuance of United States Patent 6,737,268 covering the generation of genetically enhanced therapeutic antigens.

2 Jun 2004

Invention could help numerous lymphedema patients around the world

After Ellen Van't Hof survived a bilateral mastectomy, six months of chemotherapy and two months of radiation she thought the worst was behind her.

30 May 2004

QRS Diagnostic gets patent approval for computer-card medical device technology

QRS Diagnostic, leader in innovative design and development of software-based medical devices, announces that the United States Patent and Trademark Office approved a new patent on its design of medical devices contained in computer cards

25 May 2004

Vasamed announces patent for a novel pulse oximeter

Vasamed, developer and supplier of hemodynamic monitoring products, announced that the U.S. Patent and Trademark Office granted it a method patent for a novel pulse oximeter that incorporates signals from a laser Doppler velocimeter (LDV) and an impedance cardiograph (ICG) to accomplish the measurement of oxygen saturation.

25 May 2004

Novogen granted Canadian patent for health supplements for the treatment of menopause symptoms

Pharmaceutical company, Novogen, has been granted patent coverage over its OTC products being sold in Canada. The patent covers the isoflavone composition of the products Promensil(TM), Rimostil(TM) and Trinovin(TM).

20 May 2004

Bio-optical CD could screen patients for thousands of disease markers while they wait

While-you-wait medical tests that screen patients for thousands of disease markers could be possible with compact-disk technology patented by Purdue University scientists.

19 May 2004

Connetics issued U.S. patent for emollient-foam technology

Connetics Corporation, a specialty pharmaceutical company that develops and commercializes dermatology products, announced today that on May 4, 2004 the United States Patent and Trademark Office (USPTO) issued to Connetics Patent No. 6,730,288 B1. The patent has 7 independent product claims, and covers a pharmaceutical aerosol foam composition having occlusive capability.

17 May 2004

Ingenium's acquisition of US patents may lead to drug discovery and development

Ingenium Pharmaceuticals AG has acquired outright US patents no. 5,994,075 and no. 6,015,670 from Incyte Corporation, the company announced today.

12 May 2004

New patent has potential for the treatment of obesity

Two researchers have announced receipt of a patent on the use of MSH analogs--chemicals that regulate fat storage and metabolism in the body.

11 May 2004

New patent to develop antibody therapies for cancer and other diseases

The University of Rochester Medical Center and Vaccinex, Inc. announced today the award of a key U.S. patent for a technology platform that can assist researchers in finding new treatments for cancer and other diseases. While the technology has many applications, one promising use is for the identification of certain proteins, called monoclonal antibodies, that are capable of seeking out and destroying harmful cells. Several companies have recently developed monoclonal antibodies as treatments for cancer, rheumatoid arthritis, and other conditions. Under an exclusive, worldwide license from the University of Rochester, Vaccinex is using the patented technology to discover and develop new monoclonal antibody therapies.

26 Mar 2004